VivoSim Labs
San Diego
About VivoSim Labs
Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $121.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2026)
- Ticker: nasdaq:ONVO
- Website: organovo.com
- Phone: (858)550-9994
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/vivosim-labs-123446 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.